Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| ethics comittee | Other Identifier | St. Franzikus Hospital Winterberg |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study investigates the etiology of psychogical disorders from a neuropsychological perspective based on monitoring and cognitive appraisal.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| AX-CPT Treatment | Experimental | Treatment with the AX-CPT |
|
| Control Group | Other | AX-CPT is merely administrated as pre-and posttest measure. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| AX-CPT | Behavioral | administration of the AX-CPT |
| |
| Measure | Description | Time Frame |
|---|---|---|
| AX-CPT (AX-Continuous Performance Test) | The AX-CPT assesses cognitive control through error rates and reaction times. Range: Error rate: 0-100%; Reaction time: measured in milliseconds Interpretation: Lower error rates and faster reaction times indicate better cognitive control performance. | from beginning (day 2) of the hospitalization to the end (day 14) of the biweekly pre-rehabilitative treatment. |
| CCFQ (Cognitive Control and Flexibility Questionnaire) | The CCFQ measures self-reported cognitive flexibility and control. Scale title: Cognitive Control and Flexibility Questionnaire Range: 1-7 per item Interpretation: Higher scores indicate greater cognitive flexibility and control. | Day 1 (pretest) and Day 14 (posttest) |
| BSI-18 (Brief Symptom Inventory - 18) | T he BSI-18 assesses psychological symptom severity in terms of depression, anxiety, and somatization.T Scale title: Brief Symptom Inventory - 18 Range: 0-4 per item Interpretation: Higher scores indicate greater symptom severity. | Day 1 (pretest) and Day 14 (posttest) |
| MHC-SF (Mental Health Continuum - Short Form) | Measures emotional, psychological, and social well-being. Range: 1-6 per item Interpretation: Higher scores indicate better mental health. | Day 1 (pretest) and Day 14 (posttest) |
| Measure | Description | Time Frame |
|---|---|---|
| General Self-Efficacy assessed via General Self-Efficacy Scale (SWE) | Evaluation of perceived self-efficacy across various life domains. Range: 1-4 per item Interpretation: Higher scores indicate greater self-efficacy. | Day 1 (pretest) and Day 14 (posttest) |
| Treatment Beliefs assessed via Palermo Questionnaire |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| St. Franziskus-Hospital Winterberg | Winterberg | North Rhine-Westphalia | 59955 | Germany |
the data contains patient-relevant information that is protected under the European General Data Protection Regulation act.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| No Interventions |
| Other |
Control group with no intervention treatment |
|
Beliefs and expectations regarding treatment effectiveness. Range: 1-5 per item Interpretation: Higher scores indicate stronger and more positive treatment beliefs. |
| Day 1 (pretest) and Day 14 (posttest) |
| ID | Term |
|---|---|
| D060825 | Cognitive Dysfunction |
| ID | Term |
|---|---|
| D003072 | Cognition Disorders |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D009483 | Neuropsychological Tests |
| ID | Term |
|---|---|
| D011581 | Psychological Tests |
| D004191 | Behavioral Disciplines and Activities |
Not provided
Not provided